Newspaper Publication of Audited Financial Result of the Company for the Quarter and year ended 31st March, 2026. Published on 23rd May, 2026 in Business Standard (English Edition) and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Link Pharma Chem Ltd published its audited financial results for Q4 and the financial year ended March 31, 2026. For FY2026, total income was Rs. 2,740.15 lakh versus Rs. 2,543.34 lakh in FY2025, showing 7.7% growth. The company swung from a net loss of Rs. 102.73 lakh in the previous year to a net profit of Rs. 76.9 lakh. EPS improved from Rs. -2.31 to Rs. 0.17. Q4 standalone showed income of Rs. 658.88 lakh and net profit of Rs. 40.86 lakh. The results were published in Business Standard (English) and Loksatta (Gujarati) on May 23, 2026.
The company demonstrated a strong turnaround from losses to profits year-on-year, with revenue growth and improved operational efficiency. Shareholders can note recovery from FY2025's loss-making position, though the Q4 loss of Rs. 0.92 EPS indicates some weakness in the final quarter.